Sonic Healthcare USA

What Sonic Healthcare USA does

Sonic Healthcare USA is the US operating division of Sonic Healthcare Limited (ASX:SHL), a global laboratory medicine group headquartered in Australia. Founded in 2007, it is the third largest laboratory medicine company in the United States, operating across 34 states through 9 operating divisions with 8,000+ employees and serving an estimated 20 million physicians and patients annually. The company's US headquarters relocated from Austin to Dallas in November 2025, consolidating operational footprint.

The company provides a broad portfolio of clinical laboratory and anatomic pathology services across hematology, oncology, dermatopathology, rheumatology, and endocrinology, supported by a workforce of more than 1,000 expert anatomical pathologists operating under a Medical Leadership model. Its service menu includes specialty tests such as the PromarkerD predictive diagnostic for diabetic kidney disease (licensed from Proteomics International in May 2023) and the 14-3-3eta rheumatoid arthritis test, alongside emerging offerings including monkeypox testing. Through the $150M acquisition of PathologyWatch in March 2024, Sonic Healthcare USA operates the dot. digital pathology platform with AI-assisted whole-slide image analysis for dermatopathology.

The business operates a B2B model serving hospitals, integrated health systems, and individual physicians including oncologists, dermatologists, rheumatologists, and endocrinologists, with revenue generated on a per-test/per-specimen basis through clinical laboratory services, anatomic pathology, and emerging companion diagnostics (entered via the May 2026 CellCarta partnership). The parent Sonic Healthcare Limited reported A$5.4B in half-year 2026 revenue, implying an annualized consolidated run-rate of approximately A$10.8B (~$7B USD) across all geographies.

Name

Sonic Healthcare USA

Legal name

Sonic Healthcare USA, Inc.

Website

https://sonichealthcareusa.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Sonic Healthcare USA is the US operating division of Sonic Healthcare Limited and the third largest US laboratory medicine company, providing clinical and anatomic pathology services to 20 million patients annually across 34 states through 9 divisions and 8,000+ staff.

Ownership category

akta.pro rank

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Clinical Laboratory Services: Provides clinical and anatomic pathology services through a nationwide network of regional diagnostic laboratories. Revenue generated from laboratory testing services billed to healthcare providers, hospitals, and insurance companies.
2. Reference Laboratory Testing: Esoteric testing services offered through Sonic Reference Laboratory and Sonic Research Network for specialized diagnostics.
3. Integrated Oncology Diagnostics: Comprehensive hematology oncology diagnostics including personalized diagnostic reports. Revenue from integrated testing services through Cairo Diagnostics acquisition.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels3 records

Core offering

Sonic Healthcare USA is a clinical and anatomic pathology laboratory network that provides diagnostic testing services to physicians, hospitals, and health systems across the United States. Operating through nine regional divisions and sub-brands (including American Esoteric Laboratories, Sunrise Medical Laboratories, Clinical Pathology Laboratories, Sonic Reference Laboratory, PathologyWatch, and Cairo Diagnostics), the company delivers routine clinical chemistry, histopathology, molecular diagnostics, cytogenetics, flow cytometry, immunohistochemistry, dermatopathology, and specialized esoteric testing.

Product overview

Sonic Healthcare USA operates as a multi-divisional clinical and anatomic pathology laboratory network with a federated structure. The company offers a comprehensive portfolio of diagnostic testing services across multiple specialized areas including clinical pathology, anatomic pathology, dermatopathology, and molecular diagnostics. The core offering consists of nine operating divisions (Anatomic Pathology, Dermatopathology, MidSouth, Northeast, Pacific, West-Southwest) plus specialized units including Sonic Research Network, Sonic Reference Laboratory, and PathologyWatch. Featured testing solutions include ThyroSeq (thyroid), Tick Borne Disease, Women's Health, Reproductive Health, COVID-19, and Monkeypox testing. Recent strategic additions include Cairo Diagnostics (hematology oncology), the PromarkerD diabetic kidney disease test, and 14-3-3eta rheumatoid arthritis test. The PathologyWatch acquisition brought AI-powered digital pathology technology ('dot.') for dermatopathology reporting. The CellCarta partnership enables companion diagnostics commercialization across oncology, autoimmune disease, and precision medicine. Services range from routine clinical chemistry to advanced molecular diagnostics, flow cytometry, cytogenetics, and digital pathology with AI-assisted analysis.

Differentiator

Problem solved

Functional benefit

Brands

• Sonic Reference Laboratory: Reference laboratory services within Sonic Healthcare USA's Sonic Research Network.
• Sonic Research Network (SRN)
• American Esoteric Laboratories (AEL)
• Sunrise Medical Laboratories
• East Side Clinical Laboratory
• Clinical Labs of Hawaii
• Clinical Pathology Laboratories (CPL)
• ProMedica Pathology Laboratories (PPL)
• PathologyWatch
• SonicMyAccess
• iMorpheus

Products and services

• Cairo Diagnostics Hematology Oncology Testing Integrated hematology oncology diagnostics combining histopathology, molecular diagnostics, cytogenetics, flow cytometry, and immunohistochemistry testing under one roof for oncologists, hematopathologists, and cancer care teams.
• PathologyWatch Digital Pathology Platform with dot. Technology Integrated end-to-end digital pathology platform for skin pathology incorporating a laboratory information system, digital pathology viewer, image storage, and AI algorithms for remote pathologist access and reporting.
• COVID-19 and Influenza Multiplex Testing Combined molecular RT-PCR assay for SARS-CoV-2 and Influenza A/B from a single specimen collection for healthcare providers.
• Monkeypox Virus Testing Molecular RT-PCR assay testing for Monkeypox virus performed under HHS authorization at Sonic's clinical laboratories.
• PromarkerD Diabetic Kidney Disease Predictive Test Predictive blood test for diabetic kidney disease using three serum protein biomarkers combined with clinical variables to predict kidney function decline in type 2 diabetes patients, offered to physicians and healthcare systems.
• 14-3-3eta Rheumatoid Arthritis Test Blood test measuring 14-3-3eta protein biomarkers to assist rheumatologists with early detection and management of rheumatoid arthritis.
• Sonic Reference Laboratory Reference laboratory offering specialized and esoteric testing services for healthcare providers, including the 14-3-3eta rheumatoid arthritis test.
• ThyroSeq Thyroid Cancer Testing Specialized thyroid cancer diagnostic testing solution for endocrinologists, surgeons, and other healthcare providers managing thyroid nodules.
• Tick Borne Disease Testing Specialized diagnostic testing for tick-borne diseases offered across Sonic Healthcare USA's laboratory network.
• Reproductive Health Testing Reproductive health diagnostic testing services offered through Sonic's laboratory network.
• Sonic Research Network (SRN) Unified network of clinical research services combining expertise from Aurora Research Institute, ProPath, and Sonic Healthcare USA clinical and anatomic pathology laboratories for end-to-end clinical research support.
• SonicMyAccess Patient Portal Online patient portal allowing patients to safely access and view their laboratory test results.

Quantifiable outcome

• Serving 20 million physicians and patients annually across 34 states
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core.

• CellCartacoreStrategic or Co-development Partner · 27 May 2026Strategic partnership making Sonic the first committed commercial laboratory partner in CellCarta's Lab Network strategy to commercialize companion diagnostics developed through CellCarta's single-site PMA CDx bridging model. CellCarta handles CDx assay development, regulatory support for FDA and European IVDR pathways, and testing, while Sonic enables commercialization through its provider-facing laboratory network. Collaboration aims to support companion diagnostic commercialization in oncology, autoimmune disease, and precision medicine settings.
• Cairo Diagnostics LLCcoreOthers · 19 August 2025Acquisition of substantially all assets of Cairo Diagnostics LLC, Cairo Diagnostics NJ, LLC and Rye Management and Logistics Corp. Cairo is a provider of comprehensive hematology oncology diagnostics based in White Plains, NY with a second laboratory in Woodcliff Lake, NJ. SHUSA integrates Cairo's medically led test menu and infrastructure into its national network.
• PathologyWatchcoreOthers · 26 March 2024Acquisition of PathologyWatch, an innovative digital pathology platform headquartered in Salt Lake City, Utah with additional laboratories in Phoenix, Arizona and Port Charlotte, Florida. PathologyWatch has developed the 'dot.' (dermatopathology optimization tool) integrated end-to-end digital pathology platform for skin pathology.
• Proteomics InternationalcoreTechnology or Integration · 10 May 2023Exclusive license agreement for commercialization of PromarkerD predictive test for diabetic kidney disease in the United States. Sonic Healthcare USA offers PromarkerD to physicians and healthcare systems through its client engagement teams. The five-year exclusive license includes commercially agreed royalties based on test sales, with milestone events for PLA Code submission and validation.
• ProMedica Health SystemcoreStrategic or Co-development Partner · 2 August 2018Joint venture partnership to enhance laboratory services for patients and healthcare providers throughout Ohio, Michigan, and parts of Indiana. The joint venture operates as ProMedica Pathology Laboratories (PPL), combining ProMedica's inpatient and outreach laboratory testing capabilities with Sonic Healthcare's outreach laboratory knowledge and esoteric testing capabilities.

Scale indicators7 records

Recent moves10 records

Expansion highlights6 records

Regional players

• PathGroup: PathGroup is a US physician-led anatomic and clinical pathology provider serving hospitals and health systems, primarily in the Southeast and Midwest. Its anatomic pathology services, medical leadership model, and hospital partnership orientation mirror several Sonic divisions, including the MidSouth and Anatomic Pathology Division.
• Mayo Clinic Laboratories: Mayo Clinic Laboratories is a reference laboratory within a major academic medical center that serves US and global health systems with esoteric and specialty testing. It competes with Sonic Reference Laboratory for hospital outreach and complex reference work.
• ARUP Laboratories: ARUP is a nonprofit reference laboratory affiliated with the University of Utah, serving US health systems with esoteric and reference testing. Its emphasis on complex, hospital-based testing overlaps substantially with Sonic Reference Laboratory's esoteric and hospital-lab partnership channels.

Broad incumbents

• Quest Diagnostics: Quest Diagnostics is the largest US clinical laboratory company, providing routine and esoteric diagnostic testing services to physicians, hospitals, and health systems nationwide. It is the primary direct competitor and scale benchmark for Sonic Healthcare USA's clinical and anatomic pathology portfolio.
• Laboratory Corporation of America (Labcorp): Labcorp is the second-largest US clinical lab and a direct competitor across routine chemistry, esoteric, and anatomic pathology testing. Its national footprint, payer relationships, and biopharma laboratory services overlap significantly with Sonic Healthcare USA's portfolio.
• Eurofins Scientific: Eurofins is a global diagnostic and testing services group with significant clinical diagnostics and biopharma service offerings across Europe and the US. As Sonic Healthcare's global peer, it overlaps with Sonic on esoteric testing, hospital outreach, and biopharma laboratory services.

Direct peers

• BioReference Laboratories: BioReference (an OPKO Health subsidiary) operates a national clinical laboratory network with a strong focus on esoteric testing, women's health, oncology, and urology. Its specialty testing focus and physician-office distribution model directly overlap with Sonic's MidSouth, Northeast, and Sonic Reference Laboratory divisions.
• NeoGenomics Laboratories: NeoGenomics is a US specialty oncology diagnostics laboratory focused on hematology, solid tumor, and molecular oncology testing. The Cairo Diagnostics acquisition and Sonic's integrated oncology testing platform directly compete with NeoGenomics' clinical offering to oncologists and hematologists.

Emerging players

• Guardant Health: Guardant Health is a US precision oncology diagnostics company specializing in liquid biopsy and genomic profiling. Its hematology oncology and molecular testing overlap with the Cairo Diagnostics integrated oncology platform at Sonic, especially as the CMO Mohammed Salama, MD highlighted plans to expand into liquid biopsy.

Others

• Philips Digital Pathology (Philips HealthSuite): Philips is a major vendor of digital pathology scanners and image management software used by pathology labs, and competes technology-wise with PathologyWatch's dot. platform. While not a direct laboratory peer, it represents the enterprise-scale imaging infrastructure against which PathologyWatch's AI-enabled dermatopathology platform is positioned.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sonic-healthcare-usa/?viewAsMember=true
• Xx.com/SonicHUSA

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sonic Healthcare USA